Cardiac transplantation in a patient with hereditary hemochromatosis: Role of adjunctive phlebotomy and erythropoietin

Journal of Heart and Lung Transplantation

Volumn 20, Issue 6, 2001, Pages 696-698

  Schofield, Richard S ^a,b   Aranda Jr , Juan M ^a   Hill, James A ^a   Streiff, Richard ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b Division of Cardiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; DIURETIC AGENT; ERYTHROPOIETIN; IRON; MILRINONE;

ADULT; ARTICLE; CARDIOMYOPATHY; CASE REPORT; ENDOCRINE FUNCTION; FEMALE; GENETIC DISORDER; HEART TRANSPLANTATION; HEMATOCRIT; HEMOCHROMATOSIS; HEMODYNAMICS; HUMAN; HUMAN TISSUE; PHLEBOTOMY; PRIORITY JOURNAL;

ADULT; ASCORBIC ACID; CARDIOMYOPATHIES; COMBINED MODALITY THERAPY; ERYTHROPOIETIN; FEMALE; HEART TRANSPLANTATION; HEMOCHROMATOSIS; HUMANS; PHLEBOTOMY;

EID: 0034993179     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(00)00212-6     Document Type: Article

References (6)

1. Haemochromatosis presenting as congestive heart failure
2. A novel MHC class I-like gene is mutated in patients with hereditary hemochromatosis
3. Survival and causes of death in cirrhotic and noncirrhotic patients with primary hemochromatosis
4. Heart transplantation in a case of juvenile hereditary hemochromatosis followed up by MRI and endomyocardial biopsies
5. Heart transplantation for end-stage heart failure caused by iron overload
6. Possible adverse health effects of vitamin C and ascorbic acid